Senior insider sale
Chief Financial Officer at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$382.9K
14.03K shares
What this filing means
HORN HOWARD plans to sell 14.03K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $382.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001950047-26-006703
Officer· Chief Financial Officer
Since Mar 2026
14.03K
Shares to sell
$382.9K
Approx. market value
4.70K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months5
Restricted Stock
Not Applicable
3/1/2026
944.00Performance Shares
Not Applicable
3/1/2026
661.00Restricted Stock
Not Applicable
10/9/2025
1.35KRestricted Stock
Not Applicable
3/1/2025
1.32KRestricted Stock
Not Applicable
10/9/2024
421.00Total acquired4.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2026 | Restricted Stock Not Applicable | 944.00 | — |
3/1/2026 | Performance Shares Not Applicable | 661.00 | — |
10/9/2025 | Restricted Stock Not Applicable | 1.35K | — |
3/1/2025 | Restricted Stock Not Applicable | 1.32K | — |
10/9/2024 | Restricted Stock Not Applicable | 421.00 | — |
| Total | 4.70K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
4.65K
Market value
$110.6K
6/1/2026
—Completed
Units to sell
4.68K
Market value
$116.6K
5/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.70K
Market value
$155.6K
7/1/2026
Total
Units
14.03K
Value
$382.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/1/2026 | 4.65K | $110.6K | — | Completed |
5/1/2026 | 4.68K | $116.6K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 4.70K | $155.6K | NASDAQ | Planned |
| Total | 14.03K | $382.9K | ||